These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35966884)

  • 1. Examination of Provider and Patient Knowledge, Beliefs, and Preferences in Integrative Oncology at a National Cancer Institute-Designated Comprehensive Cancer Center.
    Mascaro JS; Catic A; Srivastava M; Diller M; Rana S; Escoffery C; Master V
    Integr Med Rep; 2022; 1(1):66-75. PubMed ID: 35966884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and Facilitators to Integrative Oncology Services in Australia: A Changed Mind Set Required.
    Hunter J; Grant S; Delaney GP; Templeman K; Ussher J; Parton C; Kellett A; Smith C
    J Altern Complement Med; 2021 Mar; 27(S1):S89-S98. PubMed ID: 33788601
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving Access to Integrative Oncology Through Group Medical Visits: A Pilot Implementation Project.
    Thompson-Lastad A; Atreya CE; Chao MT; Pollak C; Dhruva A; Santana T; Abrams DI
    J Altern Complement Med; 2019 Jul; 25(7):733-739. PubMed ID: 31314561
    [No Abstract]   [Full Text] [Related]  

  • 4. Australian integrative oncology services: a mixed-method study exploring the views of cancer survivors.
    Hunter J; Ussher J; Parton C; Kellett A; Smith C; Delaney G; Oyston E
    BMC Complement Altern Med; 2018 May; 18(1):153. PubMed ID: 29743054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative oncology and complementary medicine cancer services in Australia: findings from a national cross-sectional survey.
    Smith CA; Hunter J; Delaney GP; Ussher JM; Templeman K; Grant S; Oyston E
    BMC Complement Altern Med; 2018 Oct; 18(1):289. PubMed ID: 30373631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Cancer care of rural dwellers through telehealth and engagement (ENCORE): protocol to evaluate effectiveness of a multi-level telehealth-based intervention to improve rural cancer care delivery.
    Pal T; Hull PC; Koyama T; Lammers P; Martinez D; McArthy J; Schremp E; Tezak A; Washburn A; Whisenant JG; Friedman DL
    BMC Cancer; 2021 Nov; 21(1):1262. PubMed ID: 34814868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of Virtual Integrative Oncology Shared Medical Appointment Series (VIOSMAS) Within Mixed Diagnosis Population.
    Loy MH; Prisco L; Parikh C
    Integr Cancer Ther; 2024; 23():15347354231223969. PubMed ID: 38243739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice Patterns on the Incorporation of Integrative Medicine Into the Oncologic Care of Patients With Cancer.
    Narayanan S; Liu W; Lopez G; Fellman B; Reddy A; Subbiah IM; Cohen L; Bruera E
    Integr Cancer Ther; 2023; 22():15347354231213045. PubMed ID: 37978821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative oncology in cancer care - implementation factors: mixed-methods systematic review.
    Kwong MH; Ho L; Li ASC; Nilsen P; Ho FF; Zhong CCW; Chung VCH
    BMJ Support Palliat Care; 2023 May; ():. PubMed ID: 37173126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoption of Telemedicine in a Rural US Cancer Center Amid the COVID-19 Pandemic: Qualitative Study.
    Mackwood M; Butcher R; Vaclavik D; Alford-Teaster JA; Curtis KM; Lowry M; Tosteson TD; Zhao W; Tosteson ANA
    JMIR Cancer; 2022 Aug; 8(3):e33768. PubMed ID: 35895904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators to implementing cancer survivorship care plans.
    Dulko D; Pace CM; Dittus KL; Sprague BL; Pollack LA; Hawkins NA; Geller BM
    Oncol Nurs Forum; 2013 Nov; 40(6):575-80. PubMed ID: 24161636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors.
    Yusuf R; Ng DQ; Torno L; Chan A
    Curr Opin Oncol; 2024 Jul; 36(4):211-222. PubMed ID: 38842014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis.
    Ralefala T; Mokokwe L; Jammalamadugu S; Legobere D; Motlhwa WS; Oyekunle AA; Grover S; Barg FK; Shulman LN; Martei YM
    Oncologist; 2021 Dec; 26(12):e2200-e2208. PubMed ID: 34390287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider perspectives on barriers and facilitators to adjuvant endocrine therapy-related symptom management.
    Samuel CA; Turner K; Donovan HAS; Beckjord E; Cardy A; Dew MA; van Londen GJ
    Support Care Cancer; 2017 Dec; 25(12):3723-3731. PubMed ID: 28681126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond efficacy: a qualitative organizational perspective on key implementation science constructs important to physical activity intervention translation to rural community cancer care sites.
    Rogers LQ; Goncalves L; Martin MY; Pisu M; Smith TL; Hessong D; Oster RA; Qu H; Shewchuk R; Iqbal F; Sheffield ME; Minter A; Baumann AA
    J Cancer Surviv; 2019 Aug; 13(4):537-546. PubMed ID: 31250353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
    Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
    JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ACTION Centre as a Model for Patient Engagement and Knowledge Translation in Integrative Oncology Practice, Training, and Research.
    Carlson LE; Karim S; Labelle LE
    Integr Cancer Ther; 2022; 21():15347354221103277. PubMed ID: 35726200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Oncology Consultations Delivered via Telehealth in 2020 and In-Person in 2019: Paradigm Shift During the COVID-19 World Pandemic.
    Narayanan S; Lopez G; Powers-James C; Fellman BM; Chunduru A; Li Y; Bruera E; Cohen L
    Integr Cancer Ther; 2021; 20():1534735421999101. PubMed ID: 33655797
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.